Characterization and proteomic analysis of ovarian cancer-derived exosomes
- PMID: 23333927
- DOI: 10.1016/j.jprot.2012.12.029
Characterization and proteomic analysis of ovarian cancer-derived exosomes
Abstract
Ovarian cancer is the most lethal type of cancer among all frequent gynecologic malignancies, because most patients present with advanced disease at diagnosis. Exosomes are important intercellular communication vehicles, released by various cell types. Here we presented firstly the protein profile of highly purified exosomes derived from two ovarian cancer cell lines, OVCAR-3 and IGROV1. The exosomes derived from ovarian cancer cell lines were round and mostly 30-100 nm in diameter when viewed under an electron microscope. The exosomal marker proteins TSG101 and Alix were detected in exosome preparations. The range of density was between 1.09 g/ml and 1.15 g/ml. A total of 2230 proteins were identified from two ovarian cell-derived exosomes. Among them, 1017 proteins were identified in both exosomes including all of the major exosomal protein markers. There were 380 proteins that are not reported in the ExoCarta database. In addition to common proteins from exosomes of various origins, our results showed that ovarian cancer-derived exosomes also carried tissue specific proteins associated with tumorigenesis and metastasis, especially in ovarian carcinoma. Based on the known roles of exosomes in cellular communication, these data indicate that exosomes released by ovarian cancer cells may play important roles in ovarian cancer progression and provide a potential source of blood-based protein biomarkers.
Copyright © 2013 Elsevier B.V. All rights reserved.
Similar articles
-
Proteomics profiling of plasma exosomes in epithelial ovarian cancer: A potential role in the coagulation cascade, diagnosis and prognosis.Int J Oncol. 2019 May;54(5):1719-1733. doi: 10.3892/ijo.2019.4742. Epub 2019 Mar 7. Int J Oncol. 2019. PMID: 30864689 Free PMC article.
-
Identification and proteomic analysis of osteoblast-derived exosomes.Biochem Biophys Res Commun. 2015 Nov 6;467(1):27-32. doi: 10.1016/j.bbrc.2015.09.135. Epub 2015 Sep 28. Biochem Biophys Res Commun. 2015. PMID: 26420226
-
Exosomes mediated pentose phosphate pathway in ovarian cancer metastasis: a proteomics analysis.Int J Clin Exp Pathol. 2015 Dec 1;8(12):15719-28. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26884841 Free PMC article.
-
A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies.J Ovarian Res. 2017 Nov 3;10(1):73. doi: 10.1186/s13048-017-0368-6. J Ovarian Res. 2017. PMID: 29100532 Free PMC article. Review.
-
Exosomes: Emerging biomarkers and targets for ovarian cancer.Cancer Lett. 2015 Oct 10;367(1):26-33. doi: 10.1016/j.canlet.2015.07.014. Epub 2015 Jul 17. Cancer Lett. 2015. PMID: 26189430 Review.
Cited by
-
Tumour extracellular vesicle-derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement-dependent cytotoxicity of tumour cells.J Extracell Vesicles. 2020 Nov;10(1):e12031. doi: 10.1002/jev2.12031. Epub 2020 Nov 28. J Extracell Vesicles. 2020. PMID: 33708358 Free PMC article.
-
Extracellular Vesicles: A Novel Tool Facilitating Personalized Medicine and Pharmacogenomics in Oncology.Front Pharmacol. 2021 Apr 30;12:671298. doi: 10.3389/fphar.2021.671298. eCollection 2021. Front Pharmacol. 2021. PMID: 33995103 Free PMC article. Review.
-
Exosomes promote pre-metastatic niche formation in ovarian cancer.Mol Cancer. 2019 Aug 13;18(1):124. doi: 10.1186/s12943-019-1049-4. Mol Cancer. 2019. PMID: 31409361 Free PMC article. Review.
-
The effects of ovarian cancer cell-derived exosomes on vascular endothelial growth factor expression in endothelial cells.EXCLI J. 2019 Oct 9;18:899-907. doi: 10.17179/excli2019-1800. eCollection 2019. EXCLI J. 2019. PMID: 31645849 Free PMC article.
-
GOLM1 as a Potential Therapeutic Target Modulates B7-H3 Secretion to Drive Ovarian Cancer Metastasis.Evid Based Complement Alternat Med. 2022 Jan 25;2022:5151065. doi: 10.1155/2022/5151065. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35116068 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous